Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction
H Gewirtz,
AJ Fischman,
S Abraham,
M Gilson,
HW Strauss,
and
NM Alpert
Department of Medicine, Rhode Island Hospital, Providence.
OBJECTIVES. This study tested the hypothesis that nonviable myocardium can be identified by quantitative measurements of regional myocardial blood flow obtained using positron emission tomography in conjunction with a mathematical model of nitrogen-13 (N-13) ammonia tracer kinetics. BACKGROUND. Under steady state basal conditions there is a minimal level of blood flow required to sustain myocardial viability. Therefore, the hypothesis predicts that regions with flow below a certain threshold are likely to be composed primarily of scar. METHODS. Studies were conducted in 26 patients with chronic myocardial infarction. Positron emission tomographic measurements of basal regional myocardial blood flow (N-13 ammonia) and fluorine-18 (F-18) fluorodeoxyglucose uptake were made and correlated with information about coronary anatomy and regional wall motion to assess myocardial viability. RESULTS. In patients with chronic myocardial infarction, normal zone blood flow (0.81 +/- 0.32 ml/min per g [mean +/- SD]) was greater (p < 0.02) than that of border zones (0.59 +/- 0.29 ml/min per g), which in turn exceeded (p < 0.001) that of infarct zone flow (0.27 +/- 0.17 ml/min per g). Good correlation was noted between relative F-18 fluorodeoxyglucose uptake and relative regional myocardial blood flow in all zones (r = 0.63, p < 0.001). Mismatch between blood flow and F-18 fluorodeoxyglucose uptake, with a single exception, was not observed in any segment with blood flow < 0.25 ml/min per g. All dyskinetic segments (n = 5) also had blood flow < 0.25 ml/min per g. In contrast, 43 of 45 myocardial segments (23 patients) with normal contraction or only mild hypokinesia had flow > or = 0.39 ml/min per g (average flow 0.78 +/- 0.35 ml/min per g). CONCLUSIONS. In patients with chronic myocardial infarction, myocardial viability is unlikely when basal regional myocardial blood flow is < 0.25 ml/min per g. Average basal flow in segments with normal or nearly normal wall motion is 0.78 +/- 0.35 ml/min per g. Thus, positron emission tomographic measurement of regional myocardial blood flow is helpful in identifying nonviable myocardium in these patients.
This article has been cited by other articles:

|
 |

|
 |
 
M. C. Ziadi, R. A. deKemp, K. A. Williams, A. Guo, B. J. W. Chow, J. M. Renaud, T. D. Ruddy, N. Sarveswaran, R. E. Tee, and R. S. B. Beanlands
Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
J. Am. Coll. Cardiol.,
August 9, 2011;
58(7):
740 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gewirtz
Cardiac PET: A Versatile, Quantitative Measurement Tool for Heart Failure Management
J. Am. Coll. Cardiol. Img.,
March 1, 2011;
4(3):
292 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Bharadwaj and S. R. Underwood
20 Nuclear medicine in heart failure
Oxford Textbook of Heart Failure,
January 1, 2011;
1(1):
med-9780199577729-chapter - med-9780199577729-chapter.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. M. Hajjiri, M. B. Leavitt, H. Zheng, A. E. Spooner, A. J. Fischman, and H. Gewirtz
Comparison of Positron Emission Tomography Measurement of Adenosine-Stimulated Absolute Myocardial Blood Flow Versus Relative Myocardial Tracer Content for Physiological Assessment of Coronary Artery Stenosis Severity and Location
J. Am. Coll. Cardiol. Img.,
June 1, 2009;
2(6):
751 - 758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Wu and J. A.C. Lima
Noninvasive Imaging of Myocardial Viability: Current Techniques and Future Developments
Circ. Res.,
December 12, 2003;
93(12):
1146 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tawakol, M. A. Forgione, M. Stuehlinger, N. M. Alpert, J. P. Cooke, J. Loscalzo, A. J. Fischman, M. A. Creager, and H. Gewirtz
Homocysteine impairs coronary microvascular dilator function in humans
J. Am. Coll. Cardiol.,
September 18, 2002;
40(6):
1051 - 1058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tawakol, H. A. Skopicki, S. A. Abraham, N. M. Alpert, A. J. Fischman, M. H. Picard, and H. Gewirtz
Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2146 - 2153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Senior and A Lahiri
Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging
Heart,
December 1, 1999;
82(6):
668 - 673.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. A. Auerbach, H. Schoder, C. Hoh, S. S. Gambhir, S. Yaghoubi, J. W. Sayre, D. Silverman, M. E. Phelps, H. R. Schelbert, and J. Czernin
Prevalence of Myocardial Viability as Detected by Positron Emission Tomography in Patients With Ischemic Cardiomyopathy
Circulation,
June 8, 1999;
99(22):
2921 - 2926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Holmvang, S. Fry, H. A. Skopicki, S. A. Abraham, N. M. Alpert, A. J. Fischman, M. H. Picard, and H. Gewirtz
Relation Between Coronary "Steal" and Contractile Function at Rest in Collateral-Dependent Myocardium of Humans With Ischemic Heart Disease
Circulation,
May 18, 1999;
99(19):
2510 - 2516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, T. Nakano, and C. B. Higgins
Hypertrophic Cardiomyopathy: MR Measurement of Coronary Blood Flow and Vasodilator Flow Reserve in Patients and Healthy Subjects
Radiology,
April 1, 1999;
211(1):
129 - 135.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. N. Kitsiou, S. L. Bacharach, M. L. Bartlett, G. Srinivasan, R. M. Summers, A. A. Quyyumi, and V. Dilsizian
13N-ammonia myocardial blood flow and uptake: Relation to functional outcome of asynergic regions after revascularization
J. Am. Coll. Cardiol.,
March 1, 1999;
33(3):
678 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Firoozan, K. Wei, A. Linka, D. Skyba, N. C. Goodman, and S. Kaul
A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations
Am J Physiol Heart Circ Physiol,
February 1, 1999;
276(2):
H446 - H455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning : An NHLBI Workshop
Circulation,
May 19, 1998;
97(18):
1848 - 1867.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Skopicki, S. A. Abraham, M. H. Picard, N. M. Alpert, A. J. Fischman, and H. Gewirtz
Effects of Dobutamine at Maximally Tolerated Dose on Myocardial Blood Flow in Humans With Ischemic Heart Disease
Circulation,
November 18, 1997;
96(10):
3346 - 3352.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. G. Camici, W. Wijns, M. Borgers, R. De Silva, R. Ferrari, J. Knuuti, A. A. Lammertsma, A. J. Liedtke, G. Paternostro, and S. F. Vatner
Pathophysiological Mechanisms of Chronic Reversible Left Ventricular Dysfunction due to Coronary Artery Disease (Hibernating Myocardium)
Circulation,
November 4, 1997;
96(9):
3205 - 3214.
[Full Text]
|
 |
|

|
 |

|
 |
 
H. G. Wolpers, W. Burchert, J. van den Hoff, R. Weinhardt, G.-J. Meyer, and P. R. Lichtlen
Assessment of Myocardial Viability by Use of 11C-Acetate and Positron Emission Tomography : Threshold Criteria of Reversible Dysfunction
Circulation,
March 18, 1997;
95(6):
1417 - 1424.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. H. Rahimtoola
Hibernating Myocardium Has Reduced Blood Flow at Rest That Increases With Low-Dose Dobutamine
Circulation,
December 15, 1996;
94(12):
3055 - 3061.
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Hata, R. Nohara, M. Fujita, R. Hosokawa, L. Lee, T. Kudo, E. Tadamura, N. Tamaki, J. Konishi, and S. Sasayama
Noninvasive Assessment of Myocardial Viability by Positron Emission Tomography With 11C Acetate in Patients With Old Myocardial Infarction: Usefulness of Low-Dose Dobutamine Infusion
Circulation,
October 15, 1996;
94(8):
1834 - 1841.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. A. Skopicki, S. A. Abraham, N. J. Weissman, A. K. Mukerjee, N. M. Alpert, A. J. Fischman, M. H. Picard, and H. Gewirtz
Factors Influencing Regional Myocardial Contractile Response to Inotropic Stimulation: Analysis in Humans With Stable Ischemic Heart Disease
Circulation,
August 15, 1996;
94(4):
643 - 650.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Shivalkar, A. Maes, M. Borgers, J. Ausma, I. Scheys, J. Nuyts, L. Mortelmans, and W. Flameng
Only Hibernating Myocardium Invariably Shows Early Recovery After Coronary Revascularization
Circulation,
August 1, 1996;
94(3):
308 - 315.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Maki, M. Luotolahti, P. Nuutila, H. Iida, L.-M. Voipio-Pulkki, U. Ruotsalainen, M. Haaparanta, O. Solin, J. Hartiala, R. Harkonen, et al.
Glucose Uptake in the Chronically Dysfunctional but Viable Myocardium
Circulation,
May 1, 1996;
93(9):
1658 - 1666.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. V.S. Marinho, B. E. Keogh, D. C. Costa, A. A. Lammerstma, P. J. Ell, and P. G. Camici
Pathophysiology of Chronic Left Ventricular Dysfunction : New Insights From the Measurement of Absolute Myocardial Blood Flow and Glucose Utilization
Circulation,
February 15, 1996;
93(4):
737 - 744.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Schulz, H. Post, S. Sakka, D. R. Wallbridge, and G. Heusch
Intraischemic Preconditioning : Increased Tolerance to Sustained Low-Flow Ischemia by a Brief Episode of No-Flow Ischemia Without Intermittent Reperfusion
Circ. Res.,
June 1, 1995;
76(6):
942 - 950.
[Abstract]
[Full Text]
|
 |
|
|